[General trends in design of drugs for chemotherapy of AIDS].
Bibikova
M V
MV
National Research Centre of Antibiotics, Moscow.
Ivanitskaia
L P
LP
Grammatikova
N E
NE
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D015195:Drug Design; D015699:HIV Envelope Protein gp120 / Q000378:metabolism; D019428:HIV Integrase Inhibitors / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D006801:Humans; D015728:Receptors, HIV / Q000378:metabolism; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D015215:Zidovudine / Q000031:analogs & derivatives / Q000627:therapeutic use
D015699:HIV Envelope Protein gp120; D019428:HIV Integrase Inhibitors; D017320:HIV Protease Inhibitors; D015728:Receptors, HIV; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D054303:HIV Reverse Transcriptase
Osnovnye napravleniia sozdaniia preparatov dlia khimioterapii SPIDa.